Prosecution Insights
Last updated: May 29, 2026
Application No. 17/617,278

BIOCIDAL COMPOSITE MATERIAL

Non-Final OA §103
Filed
Dec 07, 2021
Priority
Jun 11, 2019 — GB 1908324.5 +1 more
Examiner
TRUONG, QUANGLONG N
Art Unit
1615
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Pennog Limited
OA Round
4 (Non-Final)
79%
Grant Probability
Favorable
4-5
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
497 granted / 632 resolved
+18.6% vs TC avg
Strong +23% interview lift
Without
With
+23.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 2m
Avg Prosecution
34 currently pending
Career history
677
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
74.9%
+34.9% vs TC avg
§102
2.2%
-37.8% vs TC avg
§112
5.2%
-34.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 632 resolved cases

Office Action

§103
DETAILED ACTIONStatus of Application The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-32 are pending. Response to Arguments/Amendments The remarks filed 1/14/2026 have been fully considered and are sufficient in overcoming the previous art rejections which are withdrawn. However, in an updated search Examiner now relies on the teachings Ghosh (US6149927A) in view of Gao (CN107032915A Machine English Translation). Since the new grounds of rejection are not necessitated by amendment, this action is made NON-FINAL. Claim Rejections - 35 USC §103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-32 are rejected under 35 U.S.C. 103 as being unpatentable over Ghosh (US6149927A) in view of Gao (CN107032915A Machine English Translation). Regarding claims 1-32, Ghosh is drawn to solid compositions containing biocidal compounds that do not rapidly release the biocidal compounds when added to a locus to be protected and methods of controlling or inhibiting the growth of microorganisms in a locus comprising introducing into or onto the locus an effective amount of the solid composition (abstract). Ghosh discloses a method of eliminating or inhibiting the growth of marine organisms on a structure comprising introducing into or onto the structure to be protected an effective amount of the composition (col. 2, ln 10-20). Ghosh discloses the term "biocidal compounds" refers to microbicides and marine antifouling agents. "Microbicide" refers to a compound capable of inhibiting the growth of or controlling the growth of microorganisms in a locus. The term "locus" does not include pharmaceutical or veterinary applications. The term "microorganism" includes, but is not limited to, fungi, bacteria, and algae (col. 2, ln 27-34). Ghosh discloses zinc 2-pyridinethiol-1-oxide (col. 2, ln 64). Ghosh discloses any conventional binder may be utilized in the marine antifouling coating incorporating the compositions. Suitable binders include, but are not limited to: acrylic resins in solvent based or aqueous systems (col. 7 ln 28). Ghosh does not explicitly disclose the presence of shell fragments in the composition. However, Gao is drawn to a zinc-rich slow-release fertilizer, comprising the following components by weight: oyster shell, polylactic acid (abstract). Gao discloses zinc-rich, off-season, pollution-free, high-efficiency slow-release fertilizer [0009]. Gao discloses aA zinc-rich, off-season, pollution-free, high-efficiency slow-release fertilizer for cauliflower comprises the following components by weight: oyster shell 81-82, polylactic acid 45-46, zinc-rich yeast 9-10, cellulase [0011]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine these references and modify the composition of Ghosh, to comprise oyster shell, as previously disclosed by Gao, and arrive at the instant invention. One of ordinary skill in the art would have been motivated to do so because Ghosh and Gao are both in the field of inhibiting the growth of microorganisms. One of ordinary skill in the art would have had a reasonable expectation of success in making the claimed composition of Ghosh in view of Gao, by applying a known technique to a known product ready for improvement to yield predictable results. One of ordinary skill in the art would have been motivated to do so because Gao discloses reducing the occurrence of pests and diseases. Further, one having ordinary still in the art would reasonably expect success in combining prior art elements according to known methods to yield predictable results, see MPEP 2141. Conclusion No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to QUANGLONG N TRUONG whose telephone number is (571)270-0719. The examiner can normally be reached on 8:00 am-5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert A Wax can be reached on 571-272-0623. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /QUANGLONG N TRUONG/Examiner, Art Unit 1615
Read full office action

Prosecution Timeline

Dec 07, 2021
Application Filed
Aug 27, 2024
Non-Final Rejection mailed — §103
Nov 22, 2024
Response Filed
Mar 19, 2025
Non-Final Rejection mailed — §103
Jun 18, 2025
Response Filed
Oct 16, 2025
Non-Final Rejection mailed — §103
Jan 14, 2026
Response Filed
May 20, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12551418
COSMETIC COTAINING ULTRAVIOLET WAVELENGTH CONVERTING SUBSTANCE AND MEDICINAL AGENT
4y 4m to grant Granted Feb 17, 2026
Patent 12539322
USE OF MULBERRY EXTRACT FOR CONTROLLING POSTPRANDIAL GLUCOSE RESPONSE
3y 3m to grant Granted Feb 03, 2026
Patent 12533309
Minoxidil Adjuvant Therapies
3y 7m to grant Granted Jan 27, 2026
Patent 12533321
POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY
2y 7m to grant Granted Jan 27, 2026
Patent 12527729
MINOXIDIL ADJUVANT THERAPIES
2y 9m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

4-5
Expected OA Rounds
79%
Grant Probability
99%
With Interview (+23.4%)
2y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 632 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month